SCHEMBL2979808

SCHEMBL2979808

CCOC(=O)CN1CCCC1c1ccc(CN(CC)CC)n1C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.39
MMEL1 Q495T6 1/20 0.34
DRD3 P35462 2/20 0.33
OPRK1 P41145 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
KMT2A Q03164 3/20 0.33
GAA P10253 1/20 0.33
ALDH1A1 P00352 3/20 0.32
POLB P06746 2/20 0.32
CYP2D6 P10635 1/20 0.32
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2979687 0.84 ALDH1A1 (0.35) KMT2AGAAALDH1A1POLBKDM4E
SCHEMBL2980038 0.80 GAA (0.42) HRH3GAAALDH1A1POLBL3MBTL1
SCHEMBL2978126 0.77 GAA (0.41) HRH3GAAALDH1A1POLBL3MBTL1
Hydrochloric Acid SCHEMBL2964835 0.76 GAA (0.41) HRH3GAAALDH1A1POLBL3MBTL1
SCHEMBL27984492 0.71 SMN1; SMN2 (0.48) HRH3MMEL1KMT2AALDH1A1KDM4E
SCHEMBL2979691 0.69 GAA (0.38) HRH3GAAALDH1A1POLBKDM4E
SCHEMBL27984087 0.68 KDM4E (0.50) KMT2AALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL2972728 0.66 CHRM2 (0.49) HRH3OPRK1KMT2AGAAALDH1A1
SCHEMBL11512490 0.66 MEN1 (0.48) MMEL1OPRK1KMT2AGAAALDH1A1
SCHEMBL4093576 0.66 HRH3 (0.53) HRH3KMT2AGAAALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776903-B2 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2010-08-17 US claimed
EP-1578416-B1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES GRUENENTHAL GMBH (DE) 2006-08-02 EP claimed
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2005-12-08 US claimed
US-7776903-B2 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2010-08-17 US disclosed
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles THPO, ADCYAP1R1, DPYD HRH3 1443/4885MMEL1 3969/4885DRD3 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.